Baillie Gifford & Co’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-603,544
Closed -$296K 301
2023
Q2
$296K Sell
603,544
-743,338
-55% -$608K ﹤0.01% 283
2023
Q1
$1.56M Sell
1,346,882
-419
-0% -$766 ﹤0.01% 259
2022
Q4
$3.61M Sell
1,347,301
-2,370,899
-64% -$6.25M ﹤0.01% 251
2022
Q3
$10.6M Buy
3,718,200
+39,216
+1% +$167K 0.01% 209
2022
Q2
$18.3M Buy
3,678,984
+139,078
+4% +$729K 0.02% 195
2022
Q1
$25.2M Buy
3,539,906
+211,420
+6% +$1.75M 0.02% 199
2021
Q4
$60.5M Buy
3,328,486
+392,452
+13% +$8.47M 0.03% 172
2021
Q3
$57.4M Buy
2,936,034
+703,456
+32% +$26.8M 0.03% 178
2021
Q2
$100M Buy
2,232,578
+1,113,235
+99% +$51.6M 0.05% 153
2021
Q1
$56.2M Buy
1,119,343
+342,283
+44% +$23.3M 0.03% 175
2020
Q4
$69.5M Buy
777,060
+171,717
+28% +$14.4M 0.04% 148
2020
Q3
$46.2M Buy
+605,343
New +$38.4M 0.03% 156

Other funds holding CELL